Clinical Trials Browser

Phase 2 × Neoplasms × Watchful Waiting × Clear all

NCT07625527 2026-06-04

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Neoplasms